Carlyle Group Inc.
Institutional investor · Portfolio as of Q3 2024
Top Holdings26 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
QUIDELORTHO CORP | 8.3M | $376.7M | 39.5% | $100.03 | -85.42% | 10 qtrssince 2022-Q2 | Decreased 0 |
SOLENO THERAPEUTICS INC | 4.1M | $205.4M | 21.5% | $26.90 | +82.61% | 7 qtrssince 2023-Q1 | Unchanged 0 |
ZOOMINFO TECHNOLOGIES INC | 11.7M | $120.4M | 12.6% | $50.72 | -92.01% | 18 qtrssince 2020-Q2 | Decreased 0 |
PHATHOM PHARMACEUTICALS INC | 3.5M | $63.2M | 6.6% | $7.87 | +122.49% | 7 qtrssince 2023-Q1 | Unchanged 0 |
Q32 BIO INC | 1.1M | $48.6M | 5.1% | $17.04 | +169.95% | 3 qtrssince 2024-Q1 | Unchanged 0 |
GETTY IMAGES HOLDINGS INC | 9.2M | $35.1M | 3.7% | $5.55 | -30.09% | 8 qtrssince 2022-Q4 | Unchanged 0 |
JASPER THERAPEUTICS INC | 1.1M | $19.9M | 2.1% | $18.80 | +0.16% | 7 qtrssince 2023-Q1 | Unchanged 0 |
INVITATION HOMES INC | 477,500 | $16.8M | 1.8% | $27.70 | +20.51% | 7 qtrssince 2023-Q1 | Unchanged 0 |
SUNPOWER INC | 4.9M | $13.8M | 1.4% | $1.39 | +110.89% | 5 qtrssince 2023-Q3 | Decreased 0 |
SEACOR MARINE HLDGS INC | 1.3M | $12.9M | 1.3% | $10.72 | -9.51% | 24 qtrssince 2018-Q4 | Increased 46 |
CUBESMART | 220,500 | $11.9M | 1.2% | $33.47 | +47.68% | 9 qtrssince 2022-Q3 | Unchanged 0 |
| 2.7M | $4.5M | 0.5% | — | — | 7 qtrssince 2023-Q1 | Unchanged 0 | |
| 2.9M | $4.2M | 0.4% | — | — | 7 qtrssince 2023-Q1 | Unchanged 0 | |
| 107,214 | $4.1M | 0.4% | $35.43 | 0.00% | 1 qtr | New 45 | |
KRISPY KREME INC | 340,748 | $3.7M | 0.4% | $14.92 | -27.88% | 3 qtrssince 2024-Q1 | Unchanged 0 |
SMART SH GLOBAL LTD | 4.8M | $3.4M | 0.4% | $1.12 | -38.39% | 10 qtrssince 2022-Q2 | Unchanged 0 |
HILLEVAX INC | 1.8M | $3.2M | 0.3% | — | — | 7 qtrssince 2023-Q1 | Unchanged 0 |
SPRUCE BIOSCIENCES INC | 2.9M | $1.3M | 0.1% | — | — | — | — |
N-ABLE INC | 93,732 | $1.2M | 0.1% | $13.07 | -0.61% | 3 qtrssince 2024-Q1 | Unchanged 0 |
SOLARWINDS CORP | 93,735 | $1.2M | 0.1% | — | — | — | — |
Carlyle Group Inc. manages $954.2M across 26 positions as of Q3 2024. Top holdings: QDEL (39.5%), SLNO (21.5%), GTM (12.6%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.
Active quarter - 2 new positions, 7 exits, 2 increased. Top move: SMHI (INCREASED, conviction 46). Portfolio: $954M across 26 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer